baber/WOPTO huggingface dataset:
Patent NZ-228597-A (NZ)
Title: Extruding reinforced tube for optical cable
Inventor: HARVEY PETER
IPC: G02B6/44
Filed: 1989-04-04
Abstract: A circumferentially rigid flexible tube for use in loosely housing at least one optical fibre in an optical cable - especially an aerial optical cable - is manufactured by forming a plurality of flexible elongate flexible bodies (6,16,26), each of which has a transverse cross-section approximating to a sector of an annulus and in each of which a multiplicity of non-metallic reinforcing elements (28) are encapsulated in and evenly distributed throughout the cross-sectional area of an extruded body of electrically insulating plastics material (29); causing each flexible body as it emerges from the extrusion die (33) to follow a helical path in such a way that the convex outer arcuate surface of the body is maintained outermost and so treating the body that the plastics material in which the reinforcing elements are encapsulated sets; laying up the helically advancing flexible bodies together to form a flexible tube (5,15,25) of circular cross-section which is rotating about its longitudinal axis and feeding at least one flexible optical fibre (21) into the bore of the tube as it is being formed; and taking up the flexible tube in such a way that any residual torsion in the tube is removed.
Patent NZ-229145-A (NZ)
Title: Manufacture of multi-stage polymer particles containing a carboxylic acid compound, which are induced to swell, forming voids within the particles
Inventor: KOWALSKI ALEXANDER
IPC: C09D7/65
Filed: 1989-05-16
Abstract: Multi-stage polymer particles containing one or more void space(s) therein are produced by sequential emulsion polymerization of at least one earlier polymer stage, encapsulation of said polymer stages with at least a final polymer stage, contacting said polymer particles with a non-polymerizable carboxylic acid to permit the acid to be absorbed onto at least one of said earlier polymer stages and swelling the polymer particles by contacting the particles with an aqueous base. When dried the particles contain void space(s) therein which produce(s) opacity in compositions in which the particles are contained.
Patent NZ-233328-A (NZ)
Title: Polypeptides produced by hepatocytes infected with p. falciparum; nucleic acid probes
Inventor: DRUILHE PIERRE
IPC: C12Q1/68
Filed: 1990-04-12
Abstract: The invention relates to a polypeptide which contains at least one peptide sequence carrying one, or more, epitope(s) characteristic of a protein produced at the sporozoite stage and in hepatocytes infected with P. falciparum, this sequence comprising a succession of 10 amino acids to the maximum number of amino acids of the following peptide arrangement; Glu-Phe-Arg-Val-Ser-Thr-Ser-Asp-Thr-Pro-Gly-Gly-Asn-Glu-Ser-Ser-Ser- Ala-Phe-Pro-Gln-Phe-Ile-Trp-Ser-Ala-Glu-Lys-Lys-Asp-Glu-Lys-Glu-Ala- Ser-Glu-Gln-Gly-Glu-Glu-Ser-His-Lys-Lys-Glu-Asn-Ser-Gln-Glu-Ser-Ala- Asn-Gly-Lys-Asp-Asp-Val-Lys-Glu-Glu-Lys-Lys-Thr-Asn-Glu-Lys-Lys-Asp- Asp-Gly-Lys-Thr-Asp-Lys-Val-Gln-Glu-Lys-Val-Leu-Glu-Lys-Ser-Pro-Lys- Glu-Phe. It also relates to the use of these polypeptides, as well as of the nucleotide sequences coding for these polypeptides, in methods for in vitro diagnosis of malaria on a biological sample originating from the individual in whom the disease is to be detected.
Patent NZ-241110-A (NZ)
Title: 7,8-methylenedioxy-n-acyl-2,3-benzodiazepine derivatives, preparation and pharmaceutical compositions thereof
Inventor: ANDRASI FERENC
IPC: C07D491/056
Filed: 1991-12-20
Abstract: The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)   R   stands for a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms; R<1>   means hydrogen; or R<1> is absent when a double bond exists between the N(3) and C(4) atoms; R<2>   means a C1-3 alkyl group; or R<1> and R<2>   together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms; R<3>   means hydrogen or a C1-4 aliphatic acyl group; R<4>   represents hydrogen; a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; and the dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R<3> and R<4> stand for hydrogen. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
Patent NZ-249278-A (NZ)
Title: Recombinant swinepox virus
Inventor: COCHRAN MARK D
IPC: C12P21/02
Filed: 1993-01-13
Abstract: The present invention relates to a recombinant swinepox virus capable of replication comprising foreign DNA inserted into a site in the swinepox viral DNA which is not essential for replication of the swinepox virus. The invention further relates to homology vectors which produce recombinant swinepox viruses by inserting foreign DNA into swinepox viral DNA.
Patent NZ-258559-A (NZ)
Title: Ergoline derivatives; their preparation and pharmaceutical compositions containing them
Inventor: MANTEGANI SERGIO
IPC: C07D457/02
Filed: 1993-11-26
Abstract: The present invention provides compounds of the formula (I)   <IMAGE>   wherein A, R1, R2 and R3 are defined as in the specification, or a pharmaceutically acceptable salt thereof. A process for their preparation and the pharmacetical compositions comprising them are also provided.
Patent NZ-259573-A (NZ)
Title: Stable composition comprising 1,2-benzoisothiazoline and dipropylene glycol; use as an industrial biocide
Inventor: PAYNE JOHN DAVID
IPC: A01N25/22
Filed: 1994-01-19
Abstract: PCT No. PCT/GB94/00100 Sec. 371 Date Jul. 19, 1995 Sec. 102(e) Date Jul. 19, 1995 PCT Filed Jan. 19, 1994 PCT Pub. No. WO94/16564 PCT Pub. Date Aug. 4, 1994Stable composition of 1,2-benzisothiazolin-3-one (BIT) in dipropylene glycol having lower pH and lower viscosity than known compositions. The BIT is present as an alkali metal salt obtained by reacting 0.75 to 1.07 moles alkali metal hydroxide with one mole BIT.
Patent NZ-259802-A (NZ)
Title: Bicyclic derivatives and pharmaceutical compositions
Inventor: BONDINELL WILLIAM EDWARD
IPC: C07D401/12
Filed: 1993-12-21
Abstract: This invention relates to compounds of formulae (I), (II), (II), wherein A<1> is O, S, N-R<1> or CHR<1>; A<4> is N-R<4> or CHR<4>; R<2> is a sidechain containing an acid or ester group; R<1>, R<4> and R<5> are substituents such as H, alkyl and aryl alkyl, and R<6> is a sidechain containing a nitrogen group; and pharmaceutically acceptable salts thereof, which are effective for inhibiting platelet aggregation, pharmaceutical compositions for effecting such activity, and a method for inhibiting platelet aggregation.
Patent NZ-289720-A (NZ)
Title: Nucleic acids coding for a telomerase, a ribonucleoprotein enzyme involved in telomere synthesis
Inventor: VILLEPONTEAU BRYANT
IPC: C12Q1/68
Filed: 1995-07-06
Abstract: Nucleic acids comprising the RNA component of a mammalian telomerase are useful as pharmaceutical, therapeutic, and diagnostic reagents.
Patent NZ-329747-A (NZ)
Title: Method of respiratory delivery of insulin as a dry powder
Inventor: PATTON JOHN S
IPC: A61K9/72
Filed: 1995-02-07
Abstract: A method and use for delivering a dose of insulin to the alveolar region of a non-human animals lungs by; a) using an aerosol device with a holding chamber with a powder entry port and mouthpiece, and insulin as a dry powder free from penetration enhancers and having an average particle size below 10ìm; b) dispersing an amount of the insulin dry powder in a gas stream to form an aerosol directed into the chamber, c) capturing the aerosol in the chamber, d) inhaling the aerosol by the patient.
Patent NZ-332428-A (NZ)
Title: Modular apparatus for metering of electric energy
Inventor: KOISTINEN JUKKA
IPC: G01R11/04
Filed: 1998-10-21
Abstract: The invention concerns an apparatus for metering of electric energy, which comprises a box-like case consisting of a bottom part (20) and of a cover part (30). The box contains various metering, control and equivalent modules (M, 50, 70, 80, 90) necessary in a meter. The box of the meter also contains a compartment (50), into which various auxiliary function cards (60) can be installed, such as receivers of network commands, communication means necessary for remote reading, and equivalent. This compartment (50) is opened into an opening (37) that has been formed in the forward edge (30c) of the cover part (30) of the meter box, so that the auxiliary function cards can be installed into the compartment (50) without opening the box of the meter. At the forward edge (20c) of the bottom part (20) of the meter box, a connector block (40) is placed, whose shield cover (100) also extends so that it covers the opening (37) on the cover part (30) of the box and, thus, the auxiliary function cards (60). Thus, the auxiliary function cards (60) are placed under the cover (100) of the connector block (40) and under its seal. Further, if necessary, the auxiliary function cards (60) can be locked in the compartment (50) so that they can be removed exclusively so that the cover (30) of the box is opened and that the calibration seal of the cover (30) is broken. <IMAGE>   <IMAGE>
Patent NZ-333169-A (NZ)
Title: Processes for preparing 1H-imidazo[4,5-c]quinolin-4-amines and certain tetrazolo[1,5-c]quinoline intermediates
Inventor: GERSTER JOHN F
IPC: C07D/
Filed: 1996-10-22
Abstract: The process comprises: 1) nitrating a tetrazolo[1,5-a]quinolin-5-ol of formula I to produce a 4-nitro-tetrazolo[1,5-a]quinolin-5-ol compound of formula II; 2) sulphonylating the compound of step 1) to produce 4-nitro-tetrazolo[1,5-a]quinolin-5-ol-5-sulphonate compound of formula III; 3) reacting the compound of step 2) with an amine to produce 4-nitro-tetrazolo[1,5-a]quinolin-5-amine compound of formula IV; 4) reducing the compound of step 3) to produce a tetrazolo[1,5-a]quinolin-4,5-diamine compound of formula V; 5) reacting the compound of formula 4) with carboxylic acid or equivalent thereof to produce a 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline compound of formula VI; 6) reacting the compound of step 5) with triphenylphosphine to produce a N-triphenylphosphinyl-1H-imidazo[4,5-c]quinolin-4-amine of formula VII; 7) hydrolyzing the compound of step 6) to produce a 1H-imidazo[4,5-c]quinolin-4-amine compound of formula VIII and 8) isolating the 1H-imidazo[4,5-c]quinolin-4-amine compound of formula VIII or pharmaceutically acceptable salt. An alternative to step 1) is to react a 4-amino-2-chloro-3-nitroquinoline with sodium azide to produce a produce 4-nitro-tetrazolo[1,5-a]quinolin-5-amine compound of formula IV; An alternative to steps 1) to 4) is to: a) reacting 4-chloro-1H-imidazo[4,5-c]quinoline with hydrazine to produce a 4-hydrazino- 1H-imidazo[4,5-c]quinoline compound and b) reacting the compound of step a) with sodium nitrate to produce 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline compound of formula VI.
Patent NZ-334430-A (NZ)
Title: Hydroforming die assembly, movement of die structures progressively reduces the cross-sectional area of the die cavity formed by the structures
Inventor: HORTON FRANK A
IPC: B21D26/02
Filed: 1997-08-21
Abstract: A die assembly having die structures that are cooperable to define a die cavity into which a metallic tubular blank can be disposed. A first die structure is moveable to seal the die cavity, and after the die cavity is sealed, the first and second die structures are moveable to reduce the cross-sectional area of the die cavity and thereby deform the metallic tubular blank within the die cavity.
Patent NZ-337874-A (NZ)
Title: Vertical cavity surface emitting laser, transverse energy emission in gain medium used to augment laser output
Inventor: MOORADIAN ARAM
IPC: H01S5/14
Filed: 1998-03-19
Abstract: A vertical cavity surface emitting laser (VCEL) has a semiconductor gain medium 22.  Energy source such as electrode 40 energises the gain medium in a first volume 40.  This causes spontaneous and stimulated emission to propagate in the gain medium in a direction 48 transverse to the fundamental cavity mode.  The transverse emission pumps the gain medium in a second volume surrounding the first.  The emission from the second volume is coupled into the fundamental cavity mode and adds to the emission coupled form the first volume, this utilises otherwise wasted transverse emission.
Patent NZ-337939-A (NZ)
Title: Insulated shipping container with coolant in jacket
Inventor: DERIFIELD RODNEY M
IPC: F25D3/00
Filed: 1998-03-25
Abstract: A shipping container (10) is disclosed including an insulated body (12) having a cavity for holding a product (22) being shipped, and having one or more cavities for holding coolant (24) in a predetermined relationship to the product. The container (10) also includes an insulated cover (40) adapted to sealably engage an open end of the insulated body after product and coolant are received therein. The cover includes one or more blocks or prongs (42) extending therefrom that are adapted to slidably engage the coolant cavities and/or the product cavity to substantially minimize air spaces in the cavities and/or seal them. The insulated body (12) and cover (40) preferably are formed from injection molded polyurethane, wrapped in a plastic film and inserted into a cardboard shipping carton (60).
Patent NZ-501863-A (NZ)
Title: Method of controlling sprout formation in potatoes by selective application of chlorpropham (CIPC), and either carvone or benzothiazole
Inventor: SCHAFER RONALD K
IPC: A01N47/20
Filed: 1998-05-20
Abstract: A method of controlling sprout growth of tubers comprises: a) treating the tubers with CIPC (isopropyl-3-chlorophenylcarbamate) to form a residue thereon in an amount effective to inhibit sprout formation of the tubers; b) treating the tubers with an organic compound selected from carvone and benzothiazole to form a residue thereon and c) storing the treated tubers whereby in use the CIPC and the organic compound exhibits a synergistic effect in inhibiting sprout formation or an enhanced inhibition sprout formation using reduced amounts of CIPC than would be required if CIPC was used alone. Or the tubers can be treated by adding a composition containing CIPC and the organic compound selected from carvone and benzothiazole to the outer surface of the tubers to form treated tubers and then storing the tubers whereby in use the CIPC and the organic compound exhibits a synergistic effect in inhibiting sprout formation or an enhanced inhibition sprout formation using reduced amounts of CIPC than would be required if CIPC was used alone.
Patent NZ-502782-A (NZ)
Title: Earthquake protection consisting of vibration-isolated mounting of buildings and objects using virtual pendulums with long cycles
Inventor: BIERWIRTH FRIEDHELM
IPC: E04H9/02
Filed: 1998-08-13
Abstract: An earthquake protection system which is entirely immune to seismic activity. The system supports buildings and other objects on virtual pendulums (Pv) configured in the form of earthquake protection modules (56). In the case of relatively low buildings, the limit load support points of said earthquake protection modules (56) move in the manner of the oscillating end of a long pendulum with a long cycle of its own, so that the object being supported is efficiently isolated from the essentially more frequent ground vibrations. The functional behaviour of the system is not affected by the extent of the base acceleration or the frequency of the ground vibration. Even in the case of a large earthquake, the object will remain still. The system can be configured for any load and any conceivable scale of vibration. Four different examples of solutions are described which apply the variants and devices derived therefrom for various applications, devices which are needed to provide support against wind force and for centring an object which is subject to wind force and has an oscillating base, and devices for isolating vertical ground oscillations.
Patent NZ-503204-A (NZ)
Title: Auction and reverse auction system, auction and reverse auction apparatus, connecting apparatus, and auction and reverse auction method
Inventor: MURPHY PAUL A
IPC: G06F19/00
Filed: 1999-12-27
Abstract: An auction system 10 has an arrangement in which a main auction apparatus 12 and sub-auction apparatus 14 are connected through a connection apparatus 16. The connection apparatus 16 determines the bidding price in the main auction apparatus 12 on the basis of the bidding price of a bidder who is overbidding in the sub-auction apparatus 14 and, submits the bidding price to the main auction apparatus 12. The connection apparatus 16 also determines the presentation price to be presented to the participants in the sub-auction apparatus 14, on the basis of the bidding price of a bidder who is overbidding in the main auction apparatus 12, as the bidding price of the bidder who is overbidding in the main auction apparatus 12, and notifies the sub-auction apparatus 14 of the presentation price
Patent NZ-504063-A (NZ)
Title: Preloadable syringe with push rod disengable from piston once syringe is loaded
Inventor: LINNEBJERG STEVEN
IPC: A61M5/315
Filed: 1998-10-23
Abstract: The hollow cylindrical syringe body (10) has a channel (12) of uniform diameter. A fluid port (14) is situated at one end. The other end defines a funnel-like opening (20) with a diameter greater than that of the channel (12). A piston (24) is moved along the channel (12) by the end of a push rod (26), which is received through the channel opening (20). A ball (30) on the push rod (26) lodges in a socket (36) in the piston (24) as the rod pushes the piston (24) toward the port (14). The socket (36) is formed of resilient fingers (32, 34), which are held by the channel wall in position to retain the ball (30) in the socket (36), such that the piston (24) can be moved along the channel (12) to load the syringe.  When the socket (36) aligns with the funnel-like opening (20) of the channel (12), the socket fingers (32, 34) spread apart to release the ball (30) from the socket (36), permitting the push rod (26) to be removed from the loaded syringe.
Patent NZ-504085-A (NZ)
Title: Use of the trans-11 isomer of octadecenoic acid for increasing the concentration of conjugated linoleic acid in milk and/or tissue fat of a ruminant
Inventor: GRIINARI MIKKO
IPC: A23K1/18
Filed: 1998-10-20
Abstract: A method for increasing the concentration of the cis-9, trans-11 isomer of octadecadienoic acid in the milk fat and/or the tissue fat of a ruminant is described. In the method the ruminant is fed the trans-11 isomer of octadecenoic acid either as such or mixed with other feed, separately or together with other fatty acids.
Patent NZ-504301-A (NZ)
Title: Automatic baking apparatus and mixbag therefor
Inventor: HEDENBERG ROLF P
IPC: A21C1/08
Filed: 1998-11-16
Abstract: An automatic baking apparatus for baking food products from dough having an upper and lower holding means (14, 16) to be affixed to either end of a flexible, sealable mix-bag which contains ingredients for dough. A dough preparation and baking station (25) has a slit (37, 41) at the top and bottom portions allowing the mix-bag to pass through the station. Kneading means (22, 24, 39, 43, 56) are used to mechanically work the ingredients in the mix-bag. The kneading means are situated in the top and bottom portions of the apparatus; the top and bottom slits (37, 41) are each formed by a set of two adjacent members (22, 24, 39, 43, 56). Each member has a kneading surface (36, 38, 40, 42) defining the slit between each set and through which slit the mix-bag passes. Each kneading surface being part of a support structure which is resilient and each support structure being attached to each respective member. At least one of the members (22, 43) being movable relative to the other member in each set.  A reciprocating mechanism creates relative reciprocating movement between the mix-bag and the slit openings of the station.  A heating means (18, 20) in at least a portion of the dough preparation and baking station (25) allows the kneaded ingredients to be baked.
Patent NZ-506024-A (NZ)
Title: Mixed micellar pharmaceutical delivery system and method of preparation
Inventor: MODI PANKAJ
IPC: A61L15/44
Filed: 1999-02-05
Abstract: A pharmaceutical composition suitable for delivery through mucosal membranes, and a process for making it.  The process comprises a)  preparing a pharmaceutical agent composition in micellar form in an aqueous medium which has an alkali metal salicylate in a concentration of from 1 to 10 wt./wt. % of the aqueous micellar pharmaceutical agent composition, an alkali metal C8 to C22 alkyl sulphate in a concentration of from 1 to 10 wt./wt. % of the aqueous micellar pharmaceutical agent composition and a pharmaceutically acceptable edetate in a concentration of from 1 to 10 wt./wt. % of the aqueous micellar pharmaceutical agent composition; b)  slowly adding the micellar pharmaceutical agent composition, while mixing, to at least one absorption enhancing compound, while continuing to mix vigorously.  The absorption enhancing compounds is selected from the group consisting of saturated phospholipid, unsaturated phospholipid, hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, octylphenoxypolyethoxyethanol, glycolic acid, lactic acid, chamomile extract, cucumber extract, oleic acid, linolenic acid, borage oil, evening primrose oil, menthol, trihydroxy oxo cholanylglycine and pharmaceutically acceptable salts of trihydroxy oxo cholarylglycine, glycerin, polyglycerin, lysine, polylysine, polidocanol alkyl ethers and analogues of polidocanol alkyl ethers, triolein and mixtures thereof, wherein the amount of each absorption enhancing compound is present in a concentration of from 1 to 10 wt./wt. % of the total formulation, and the total concentration of alkali metal salicylate, alkali metal C8 to C22 alkyl sulphate, edetate and absorption enhancing compounds is less than 50 wt./wt. % of the formulation.
Patent NZ-508198-A (NZ)
Title: Flavoured noodles where the flavour ingredients are preheated at a temperature between 60 to 100 degrees Celsius for 10 to 90 minutes
Inventor: TEH SHIOK GUAT
IPC: A23L27/21
Filed: 1999-06-08
Abstract: A process for the preparation of flavoured noodles which comprises blending flour and water to form a dough, sheeting the dough to form dough sheets, slitting the dough sheets into strips of noodles of the desired width, steaming the noodles to gelatinise the starch, then frying or air drying the noodles and cooling the fried or air dried noodles characterised in that flavour ingredients are preheated at a temperature of from 60 DEG to 100 DEG C for a period of from 10 to 90 minutes and the preheated flavour ingredients are added to the dough ingredients or applied to the dough sheets.
Patent NZ-510546-A (NZ)
Title: Saddle with sealed air bags front and rear
Inventor: BATES RONALD GORDON
IPC: B68C1/08
Filed: 2001-03-15
Abstract: Sealed air bags 4 are provided in the saddle and packing material 6 is provided which is capable of being adjustable, so as to vary the padding effect of the packing material.
Patent NZ-511384-A (NZ)
Title: A trap with pre-tensioned material located around body of animal
Inventor: HAYCOCK PHILLIP JOHN
IPC: A01M23/24
Filed: 2001-04-27
Abstract: A trap is configured to apply pre-tensioned material about the body of an animal by release of a trigger mechanism.